Health
The Indian Express

Antibiotics losing their power against infections, warns ICMR

Source Entity

The Indian Express

November 20, 2026
Antibiotics losing their power against infections, warns ICMR

The ICMR's 2025 report reveals that common bacteria are increasingly resistant to standard and powerful antibiotics in India. This growing antimicrobial resistance threatens routine medical procedures and highlights a critical public health crisis.

The Silent Crisis: Antibiotic Resistance in India

The landscape of modern medicine is built upon the efficacy of antibiotics, which have long served as our primary defense against bacterial infections. From routine surgeries to the specialized care of premature infants, these drugs are foundational to medical survival. However, a new report from the Indian Council of Medical Research (ICMR) indicates that this foundation is cracking, as bacteria are evolving to resist the very treatments doctors have relied upon for decades.

Findings from the AMRSN Annual Report 2025

The Antimicrobial Resistance Surveillance and Research Network (AMRSN) Annual Report 2025 provides a sobering diagnostic of the current state of clinical care in India. The data confirms that common bacteria are no longer responding to standard antibiotic regimens. This shift means that infections once considered easily manageable are now presenting significant challenges, forcing clinicians to reconsider their treatment protocols in real-time.

The Impact of Resistant Pathogens

Central to the report’s findings is the behavior of pathogens such as E. coli and Klebsiella pneumoniae. These bacteria, which are responsible for a wide range of illnesses including urinary tract infections, pneumonia, and bloodstream infections, are demonstrating high levels of resistance. Perhaps most concerning is the documented resistance to carbapenems—a class of powerful antibiotics typically reserved for the most serious, hospital-acquired infections. When these last-resort medications fail, the clinical options for patients narrow significantly, increasing the risk of mortality.

Expanding the Scope of Surveillance

Historically, concerns regarding antimicrobial resistance (AMR) were often associated with large, tertiary-care institutions. However, the 2025 report marks a significant milestone by including data from 34 secondary-care hospitals. This inclusion reveals that resistance is not confined to specialized facilities but is an escalating issue across the broader healthcare spectrum. This expansion confirms that the threat of AMR is systemic and requires a more comprehensive approach to surveillance and antibiotic stewardship.

Broader Implications and Future Trends

The implications of this report are profound. As common bacteria continue to defy standard treatments, the efficacy of routine medical interventions—including elective surgeries and life-saving procedures—is placed at risk. Without urgent intervention, we face a future where simple infections could once again become life-threatening. Moving forward, the medical community must prioritize the rational use of antibiotics and invest in robust diagnostic tools to ensure that these essential medicines remain effective for future generations.

Verification Required?

Read the full report from the primary source

Go to The Indian Express